Nixon Peabody Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$571K Sell
7,301
-47
-0.6% -$3.68K 0.04% 107
2025
Q1
$533K Sell
7,348
-328
-4% -$23.8K 0.05% 110
2024
Q4
$568K Buy
7,676
+29
+0.4% +$2.15K 0.05% 95
2024
Q3
$505K Sell
7,647
-550
-7% -$36.3K 0.04% 98
2024
Q2
$757K Sell
8,197
-733
-8% -$67.7K 0.07% 79
2024
Q1
$853K Buy
8,930
+495
+6% +$47.3K 0.08% 74
2023
Q4
$643K Buy
+8,435
New +$643K 0.07% 76
2022
Q1
Sell
-7,806
Closed -$1.01M 84
2021
Q4
$1.01M Buy
+7,806
New +$1.01M 0.31% 55
2021
Q3
Sell
-1,934
Closed -$200K 72
2021
Q2
$200K Buy
+1,934
New +$200K 0.08% 68
2021
Q1
Sell
-2,226
Closed -$203K 71
2020
Q4
$203K Buy
+2,226
New +$203K 0.09% 69
2020
Q1
Sell
-3,147
Closed -$245K 78
2019
Q4
$245K Sell
3,147
-105
-3% -$8.17K 0.12% 72
2019
Q3
$238K Sell
3,252
-1,509
-32% -$110K 0.13% 70
2019
Q2
$293K Sell
4,761
-1,335
-22% -$82.2K 0.17% 67
2019
Q1
$389K Sell
6,096
-1,839
-23% -$117K 0.25% 62
2018
Q4
$405K Sell
7,935
-840
-10% -$42.9K 0.32% 61
2018
Q3
$509K Sell
8,775
-5,475
-38% -$318K 0.35% 61
2018
Q2
$691K Sell
14,250
-5,415
-28% -$263K 0.54% 56
2018
Q1
$915K Sell
19,665
-5,235
-21% -$244K 0.82% 46
2017
Q4
$936K Sell
24,900
-555
-2% -$20.9K 0.81% 44
2017
Q3
$927K Sell
25,455
-4,125
-14% -$150K 0.84% 44
2017
Q2
$1.17M Sell
29,580
-4,290
-13% -$169K 1.08% 39
2017
Q1
$1.06M Sell
33,870
-3,960
-10% -$124K 1% 40
2016
Q4
$1.18M Sell
37,830
-2,220
-6% -$69.4K 1.15% 39
2016
Q3
$1.61M Sell
40,050
-7,440
-16% -$299K 1.58% 31
2016
Q2
$1.58M Sell
47,490
-9,885
-17% -$329K 1.37% 29
2016
Q1
$1.69M Sell
57,375
-1,545
-3% -$45.4K 1.5% 25
2015
Q4
$1.55M Buy
+58,920
New +$1.55M 1.41% 23